ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $266,000 | -69.1% | 5,791 | -55.4% | 0.00% | -100.0% |
| Q4 2021 | $861,000 | +19.7% | 12,986 | +12.8% | 0.00% | – |
| Q3 2021 | $719,000 | -15.1% | 11,512 | +12.5% | 0.00% | -100.0% |
| Q2 2021 | $847,000 | +31.5% | 10,233 | +5.3% | 0.00% | – |
| Q1 2021 | $644,000 | +16.2% | 9,718 | +34.7% | 0.00% | – |
| Q4 2020 | $554,000 | +99.3% | 7,214 | +11.8% | 0.00% | – |
| Q3 2020 | $278,000 | +12.1% | 6,453 | +12.5% | 0.00% | – |
| Q2 2020 | $248,000 | -73.6% | 5,735 | -82.5% | 0.00% | -100.0% |
| Q1 2020 | $941,000 | -51.5% | 32,711 | +7.0% | 0.00% | -50.0% |
| Q4 2019 | $1,939,000 | -45.9% | 30,572 | -76.0% | 0.00% | -50.0% |
| Q3 2019 | $3,587,000 | -25.1% | 127,295 | -29.6% | 0.00% | -20.0% |
| Q2 2019 | $4,788,000 | +378.3% | 180,693 | +231.3% | 0.01% | +400.0% |
| Q1 2019 | $1,001,000 | – | 54,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |